Edwards Lifesciences (NYSE:EW) reported fourth-quarter sales of $1.39 billion, beating the consensus of $1.36 billion. This ...

As tools become more precise and non-invasive, doctors are able to diagnose and treat heart conditions with greater accuracy and efficiency.

Executives expect a new label indication and a hoped-for easing of hospital capacity constraints to accelerate sales this ...

JAMESTOWN — Two Sanford Health Fargo cardiology providers offer outreach services at Sanford Jamestown 2nd Ave. Clinic. Outreach services are offered on the second and fourth Wednesday of every month.

Edwards Lifesciences stock rose slightly late Tuesday on strong sales of its TAVR procedures, leading to a top- and bottom-line beat.

When Nate and Marion Weeks got married 35 years ago, little did they know they’d each undergo heart surgery performed by the same doctor 18 years apart.

Bleakley Financial Group LLC lowered its stake in Edwards Lifesciences Co. (NYSE:EW – Free Report) by 5.3% during the 4th ...

Edwards Lifesciences Corporation (NYSE:EW) develops medical innovations for heart disease and critical care monitoring. Its ...

Patients aged between 50 to 70 years with a mechanical heart valve replacement had better long-term survival compared to those with a biological valve, new research has found.

The data are observational but intuitive, say experts. Further work might define where T-TEER’s greatest benefit lies.